Patiromer With or Without Food for the Treatment of Hyperkalemia
Public ClinicalTrials.gov record NCT02694744. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Effect of Food: An Open-Label, Randomized, Parallel Group Phase 4 Study of the Efficacy and Safety of Patiromer for Oral Suspension With or Without Food for the Treatment of Hyperkalemia (TOURMALINE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of patiromer administered once daily (QD) when given with food compared to without food (experimental treatment group) for the treatment of hyperkalemia (high potassium in the blood).
Study identification
- NCT ID
- NCT02694744
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2016 (Type not available)
- Primary completion
- Jul 2016 (Actual)
- Completion
- Aug 2016 (Actual)
- Last update posted
- May 12, 2021
2016
United States locations
- U.S. sites
- 29
- U.S. states
- 13
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site 12 | Fountain Valley | California | 92708 | — |
| Investigator Site 11 | Huntington Beach | California | 92648 | — |
| Investigator Site 38 | Palm Springs | California | 92262 | — |
| Investigator Site 20 | Riverside | California | 92505 | — |
| Investigator Site 21 | San Dimas | California | 91773 | — |
| Investigator Site 24 | Denver | Colorado | 80230 | — |
| Investigator Site 30 | Edgewater | Florida | 32132 | — |
| Investigator Site 10 | Hialeah | Florida | 33012 | — |
| Investigator Site 13 | Hollywood | Florida | 33021 | — |
| Investigator Site 17 | Lauderdale Lakes | Florida | 33313-1638 | — |
| Investigator Site 16 | Lauderdale Lakes | Florida | 33319 | — |
| Investigator Site 15 | Miami | Florida | 33015 | — |
| Investigator Site 43 | Miami | Florida | 33147 | — |
| Investigator Site 18 | Pembroke Pines | Florida | 33028 | — |
| Investigator Site 27 | Tampa | Florida | 33614 | — |
| Investigator Site 44 | Meridian | Idaho | 83642 | — |
| Investigator Site 39 | Aurora | Illinois | 60504 | — |
| Investigator Site 23 | Flint | Michigan | 48504 | — |
| Investigator Site 34 | Kansas City | Missouri | 64111 | — |
| Investigator Site 41 | Las Vegas | Nevada | 89106 | — |
| Investigator Site 37 | Flushing | New York | 11355 | — |
| Investigator Site 36 | Norman | Oklahoma | 73069 | — |
| Investigator Site 40 | Jackson | Tennessee | 38305 | — |
| Investigator Site 33 | Dallas | Texas | 75231 | — |
| Investigator Site 26 | San Antonio | Texas | 78202 | — |
| Investigator Site 29 | San Antonio | Texas | 78207 | — |
| Investigator Site 28 | San Antonio | Texas | 78215 | — |
| Investigator Site 25 | San Antonio | Texas | 78229 | — |
| Investigator Site 22 | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02694744, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02694744 live on ClinicalTrials.gov.